A study led by Hospital Clínic-IDIBAPS sheds light on how this rare type of lymphoma evolves and why some tumor cells eventually outcompete others.
A study led by the IDIBAPS Molecular genetics of paediatric lymphomas research group has identified genetic, biological and clinical differences b...
Last week, the CRIS Foundation Against Cancer celebrated CRIS Science Day 2026. The event included the award ceremony for the CRIS Research Program...
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples...
The project led by Patricia Pérez Galán, the head of IDIBAPS’ Microenvironment in lymphoma pathogenesis and therapy research group, is the continua...
The model was created by injecting tumour cells from a patient into a mouse. This makes it possible to imitate the leukaemia’s transformation into...
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clini...
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives...
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
